Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases

Emilia S. Olson, Tao Jiang, Todd A. Aguilera, Quyen T. Nguyen, Lesley G. Ellies, Miriam Scadeng, Roger Y. Tsien

Research output: Contribution to journalArticle

396 Citations (Scopus)

Abstract

High-resolution imaging of molecules intrinsically involved in malignancy and metastasis would be of great value for clinical detection and staging of tumors. We now report in vivo visualization of matrix metalloproteinase activities by MRI and fluorescence of dendrimeric nanoparticles coated with activatable cell penetrating peptides (ACPPs), labeled with Cy5, gadolinium, or both. Uptake of such nanoparticles in tumors is 4- to 15-fold higher than for unconjugated ACPPs. With fluorescent molecules, we are able to detect residual tumor and metastases as small as 200 μm, which can be resected under fluorescence guidance and analyzed histopathologically with fluorescence microscopy. We show that uptake via this mechanism is comparable to that of other near infrared protease sensors, with the added advantage that the approach is translatable to MRI. Once activated, the Gd-labeled nanoparticles deposit high levels (30-50 μM) of Gd in tumor parenchyma with even higher amounts deposited in regions of infiltrative tumor, resulting in useful T1 contrast lasting several days after injection. These results should improve MRI-guided clinical staging, presurgical planning, and intraoperative fluorescence-guided surgery. The approach may be generalizable to deliver radiation-sensitizing and chemotherapeutic agents.

Original languageEnglish (US)
Pages (from-to)4311-4316
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume107
Issue number9
DOIs
StatePublished - Mar 2 2010

Fingerprint

Cell-Penetrating Peptides
Optical Imaging
Nanoparticles
Peptide Hydrolases
Fluorescence
Neoplasms
Radiation-Sensitizing Agents
Neoplasm Metastasis
Neoplasm Staging
Gadolinium
Residual Neoplasm
Matrix Metalloproteinases
Fluorescence Microscopy
Injections

Keywords

  • Dendrimeric nanoparticles
  • Molecular amplification
  • Molecular navigation
  • Targeted imaging agent
  • Transgenic tumor model

ASJC Scopus subject areas

  • General

Cite this

Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. / Olson, Emilia S.; Jiang, Tao; Aguilera, Todd A.; Nguyen, Quyen T.; Ellies, Lesley G.; Scadeng, Miriam; Tsien, Roger Y.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, No. 9, 02.03.2010, p. 4311-4316.

Research output: Contribution to journalArticle

Olson, Emilia S. ; Jiang, Tao ; Aguilera, Todd A. ; Nguyen, Quyen T. ; Ellies, Lesley G. ; Scadeng, Miriam ; Tsien, Roger Y. / Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. In: Proceedings of the National Academy of Sciences of the United States of America. 2010 ; Vol. 107, No. 9. pp. 4311-4316.
@article{72a8078f8ea14b9683addb5e0ead490b,
title = "Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases",
abstract = "High-resolution imaging of molecules intrinsically involved in malignancy and metastasis would be of great value for clinical detection and staging of tumors. We now report in vivo visualization of matrix metalloproteinase activities by MRI and fluorescence of dendrimeric nanoparticles coated with activatable cell penetrating peptides (ACPPs), labeled with Cy5, gadolinium, or both. Uptake of such nanoparticles in tumors is 4- to 15-fold higher than for unconjugated ACPPs. With fluorescent molecules, we are able to detect residual tumor and metastases as small as 200 μm, which can be resected under fluorescence guidance and analyzed histopathologically with fluorescence microscopy. We show that uptake via this mechanism is comparable to that of other near infrared protease sensors, with the added advantage that the approach is translatable to MRI. Once activated, the Gd-labeled nanoparticles deposit high levels (30-50 μM) of Gd in tumor parenchyma with even higher amounts deposited in regions of infiltrative tumor, resulting in useful T1 contrast lasting several days after injection. These results should improve MRI-guided clinical staging, presurgical planning, and intraoperative fluorescence-guided surgery. The approach may be generalizable to deliver radiation-sensitizing and chemotherapeutic agents.",
keywords = "Dendrimeric nanoparticles, Molecular amplification, Molecular navigation, Targeted imaging agent, Transgenic tumor model",
author = "Olson, {Emilia S.} and Tao Jiang and Aguilera, {Todd A.} and Nguyen, {Quyen T.} and Ellies, {Lesley G.} and Miriam Scadeng and Tsien, {Roger Y.}",
year = "2010",
month = "3",
day = "2",
doi = "10.1073/pnas.0910283107",
language = "English (US)",
volume = "107",
pages = "4311--4316",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "9",

}

TY - JOUR

T1 - Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases

AU - Olson, Emilia S.

AU - Jiang, Tao

AU - Aguilera, Todd A.

AU - Nguyen, Quyen T.

AU - Ellies, Lesley G.

AU - Scadeng, Miriam

AU - Tsien, Roger Y.

PY - 2010/3/2

Y1 - 2010/3/2

N2 - High-resolution imaging of molecules intrinsically involved in malignancy and metastasis would be of great value for clinical detection and staging of tumors. We now report in vivo visualization of matrix metalloproteinase activities by MRI and fluorescence of dendrimeric nanoparticles coated with activatable cell penetrating peptides (ACPPs), labeled with Cy5, gadolinium, or both. Uptake of such nanoparticles in tumors is 4- to 15-fold higher than for unconjugated ACPPs. With fluorescent molecules, we are able to detect residual tumor and metastases as small as 200 μm, which can be resected under fluorescence guidance and analyzed histopathologically with fluorescence microscopy. We show that uptake via this mechanism is comparable to that of other near infrared protease sensors, with the added advantage that the approach is translatable to MRI. Once activated, the Gd-labeled nanoparticles deposit high levels (30-50 μM) of Gd in tumor parenchyma with even higher amounts deposited in regions of infiltrative tumor, resulting in useful T1 contrast lasting several days after injection. These results should improve MRI-guided clinical staging, presurgical planning, and intraoperative fluorescence-guided surgery. The approach may be generalizable to deliver radiation-sensitizing and chemotherapeutic agents.

AB - High-resolution imaging of molecules intrinsically involved in malignancy and metastasis would be of great value for clinical detection and staging of tumors. We now report in vivo visualization of matrix metalloproteinase activities by MRI and fluorescence of dendrimeric nanoparticles coated with activatable cell penetrating peptides (ACPPs), labeled with Cy5, gadolinium, or both. Uptake of such nanoparticles in tumors is 4- to 15-fold higher than for unconjugated ACPPs. With fluorescent molecules, we are able to detect residual tumor and metastases as small as 200 μm, which can be resected under fluorescence guidance and analyzed histopathologically with fluorescence microscopy. We show that uptake via this mechanism is comparable to that of other near infrared protease sensors, with the added advantage that the approach is translatable to MRI. Once activated, the Gd-labeled nanoparticles deposit high levels (30-50 μM) of Gd in tumor parenchyma with even higher amounts deposited in regions of infiltrative tumor, resulting in useful T1 contrast lasting several days after injection. These results should improve MRI-guided clinical staging, presurgical planning, and intraoperative fluorescence-guided surgery. The approach may be generalizable to deliver radiation-sensitizing and chemotherapeutic agents.

KW - Dendrimeric nanoparticles

KW - Molecular amplification

KW - Molecular navigation

KW - Targeted imaging agent

KW - Transgenic tumor model

UR - http://www.scopus.com/inward/record.url?scp=77749297971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77749297971&partnerID=8YFLogxK

U2 - 10.1073/pnas.0910283107

DO - 10.1073/pnas.0910283107

M3 - Article

VL - 107

SP - 4311

EP - 4316

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 9

ER -